International Congress London 2016

Saturday, 03.09.2016
Sunday, 04.09.2016
Monday, 05.09.2016
Tuesday, 06.09.2016
Wednesday, 07.09.2016


Sponsored symposia:

Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.

The stage I non-small-cell lung cancer

Chairs: Dragan R. Subotic (Belgrade, Republic of Serbia), Nicolas Schönfeld (Berlin, Germany)
Aims: This session aims to provide a comprehensive and updated overview of issues related to early stage lung cancer that are still being debated. These issues include the optimal diagnostics, the benefits of molecular diagnostics and biomarkers, the factors that influence the treatment outcome, and the rapidly changing spectrum of surgical options for stage I NSCLC.
Biological markers
Virginie Westeel (Besançon, France)
WebcastSlide presentation
WebcastSlide presentation
Role of CT and PET in detecting non-aggressive stage IA NSCLC
Walter De Wever (Leuven, Belgium)
WebcastSlide presentation
WebcastSlide presentation
Wide therapeutic spectrum for limited disease: lobectomy vs. segmentectomy, and video-assisted thoracoscopic surgery (VATS) vs. open surgery
Martin Hürtgen (Koblenz, Germany)
WebcastSlide presentation
WebcastSlide presentation
Survival predictors
Paul E. Van Schil (Edegem (Antwerp), Belgium)
WebcastSlide presentation
WebcastSlide presentation